Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

IRBs To Be Subject Of House Hearing After “Congressional Sting Operation”

This article was originally published in The Pink Sheet Daily

Executive Summary

CEO of Coast Institutional Review Board, which approved an imaginary study, will testify before Rep. Stupak’s subcommittee.

You may also be interested in...



IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny

Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.

IRB Oversight: HHS’ Registration Practices, Firms Conduct To Face Greater Scrutiny

Hearing in House may boost prospects of legislation that would impose new requirements on the initial approval of clinical trials.

House Energy & Commerce To Continue Foraging Through Vytorin Data

The House Energy & Commerce Committee intends to keep hounding Merck and Schering-Plough for data and internal communications on how the company handled the release of information from three trials on Vytorin (simvastatin/ezetimibe)

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS069171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel